Table 1. Characteristics of LS sample series.
Predisposing gene | MMR status | CIMP status* | ||||||
---|---|---|---|---|---|---|---|---|
MLH1 | MSH2 | MSH6 | MSI (high) | MSS | Negative | Positive | ND | |
Colorectal specimens (n = 29) | 22 (76 %) | 3 (10 %) | 4 (14 %) | 29 (100 %) | 0 | 18 (62 %) | 11 (38 %) | 0 |
Adenoma (n = 11) | 10 (91 %) | 1 (9 %) | 0 | 11 (100 %) | 0 | 9 (82 %) | 2 (18 %) | 0 |
Carcinoma (n = 18) | 12 (67 %) | 2 (11 %) | 4 (22 %) | 18 (100 %) | 0 | 9 (50 %) | 9 (50 %) | 0 |
Ovarian carcinoma (n = 16) | 13 (81 %) | 3 (19 %) | 0 | 16 (100 %) | 0 | 12 (75 %) | 3 (19 %) | 1 (6 %) |
Total (n = 45) | 35 (78 %9 | 6 (13 %) | 4 (9 %) | 45 (100 %) | 0 | 30 (67 %) | 14 (31 %) | 1 (2 %) |
*Determined by MS-MLPA (ME042-B2 for colorectal tumors and ME001-C1 for ovarian carcinomas; see Materials and Methods).
ND, could not be determined due to shortage of DNA.